In this work, metabolomic profile
changes in milk from cows affected
by mastitis and treated with enrofloxacin (ENR) have been studied
using LC-HRMS techniques. Principal component analysis was applied
to the obtained results, and the interest was focused on changes affecting
compounds without a structural relationship to ENR. Most of the compounds,
whose concentrations were modified as a result of the pharmacological
treatment and/or the pathological status, were related to amino acids
and peptides. Compounds that may become possible biomarkers for either
disease or treatment have been detected. Additionally, the alterations
caused by thermal processes, such as those applied to milk before
consumption, on the identified metabolites have also been considered.